Financial Shenanigans
Financial Shenanigans
First Solar's reported 2025 economics — 41% gross margin, $1.5B net income, $2.1B operating cash flow — are real numbers but lean heavily on government policy and balance-sheet plumbing rather than underlying module economics. Section 45X advanced manufacturing credits were recognized as a $1.6B reduction to cost of sales (most of the company's gross profit) and ~$1.4B in cash from selling those credits to third parties was the single largest contributor to operating cash flow. Strip both out and FY2025 looks more like a roughly 10% gross-margin business with operating cash flow of ~$0.6B against $0.9B of capex. We grade the file Elevated (54/100): the accounting itself is GAAP-conforming, but the disclosed reliance on 45X, the receivables build (DSO has more than doubled since 2021), recourse factoring routed through CFO, customer-default litigation, and a fresh post-FY25 securities class-action investigation collectively raise the bar for owning the business at premium multiples.
The Forensic Verdict
Forensic Risk Score (0-100)
Red Flags
Yellow Flags
CFO / Net Income (3Y)
FCF / Net Income (3Y)
Accrual Ratio (3Y avg)
Reported Gross Margin FY25
Gross Margin ex-45X (est.)
Grade: Elevated. The dominant earnings and cash-flow drivers are policy-derived (Section 45X) and balance-sheet-mediated (factoring, customer prepayments, tax-credit monetization). None of these are accounting violations, but they are not equivalent to organic module economics. On top of that, FY2025 disclosed: a Series 7 product-quality liability, the BP/Lightsource customer-default litigation seeking $405M+, and DSO of 121 days versus 47 days in FY2021. A new class-action investigation was opened in January and March 2026 by Pomerantz LLP and others following the Q4 2025 earnings miss and FY2026 guidance reset.
The two thesis-relevant items are C1 (financing inflows in CFO) and D2 (balance-sheet distortion). Both reflect the same underlying mechanic: the IRA's Section 45X production credit is the primary economic engine in FY2024 and FY2025, and management is using receivable factoring with recourse plus customer advance payments to bridge collection timing. None of this is hidden, but the headline numbers without the disclosure context overstate sustainable run-rate cash generation.
Breeding Ground
The governance backdrop is institutional and clean on paper, but two structural features deserve underwriting attention: a CEO who came up through the CFO seat, and a 2020 securities-fraud settlement that named the same kinds of issues now resurfacing.
The governance file is not a free pass. A 2020 securities-fraud settlement on substantively similar themes — manufacturing defect concealment and revenue-recognition aggressiveness — is the single most important breeding-ground signal, especially given the live Series 7 quality issue and the BP/Lightsource customer dispute. The CEO's path through the controllership and CFO seats means the same person who set the accounting culture in 2012-2016 now runs the company. Compensation is tied to a metric that excludes production start-up and underutilization, which is precisely where a manufacturer ramping five US factories in three years would absorb the most negative variance.
Earnings Quality
The income statement is GAAP-correct, but the engine is policy support. Section 45X recognized in cost of sales was $1.6B in FY2025 — equal to ~76% of reported gross profit, and almost as much as net income.
The disclosed 45X benefit recognized as a reduction to cost of sales was $1.6B in FY2025; FY2024 is estimated using disclosed credits sold ($857M Visa transaction at $818M cash plus prior balances) and FY2023 based on the $687M Fiserv transaction. Without the credit, gross margin in FY2025 would be roughly 10% — in the historical range of 17-25% that the company reported pre-IRA, but materially below it because tariff and logistics costs that were absorbed in FY2025 (US production mix shift) would not be offset.
DSO went from 47 days in FY2021 to 121 days in FY2025. The MD&A explicitly attributes the FY2025 SG&A increase to "higher expected credit losses from an increase in the aging of certain accounts receivable" and "higher costs for certain legal matters." Receivables grew at a 58.6% three-year CAGR while revenue grew at 25.8% — a 280 percentage-point gap in FY2023 alone. Some of this is mechanical (US module sales have longer payment terms; payment timing is project-linked), but the absolute level is now well above any reasonable interpretation of normal terms for an investment-grade utility customer base.
Cash Flow Quality
FY2025 operating cash flow of $2.06B was the headline number from Q4 results. The underlying composition is more fragile than the print suggests.
The 45X cash-sale figures are derived directly from disclosed transactions: in FY2024, $616M from the Visa transaction (December 2024) plus the full $659M Fiserv tail from FY2023 vintage (received during 2024), totaling ~$1.27B; in FY2025, the Visa balance ($202M), $668M from the June/July transactions, and $573M of the October transaction ($95M expected in Q1 2026), totaling ~$1.44B. Stripping these out, FY2024 OCF goes essentially flat and FY2025 OCF falls to roughly $0.6B — meaningful, but not enough to fund $0.9B in capex and not consistent with a 41% gross-margin business.
The five-year cumulative free cash flow is negative $0.24 billion despite $4.08B of cumulative net income. CFO/NI of 1.06 over three years and 1.22 over five years looks acceptable but is propped up by the 45X cash sales that account for roughly half of cumulative OCF. Working capital was a $1.66B aggregate drag over five years, with FY2023 alone consuming $1.33B as receivables and inventory exploded ahead of the FY24-25 ramp. The FY2025 inventory drawdown contributed $348M to OCF — a one-off help that does not repeat.
Recourse factoring is now in CFO. The 10-K explicitly notes that "factoring certain trade receivables with recourse" was "accounted for as secured borrowings," and that the resulting interest expense drove FY25 net interest cost up by $5.3M. The amount of factored receivables is not disclosed in the MD&A excerpt, but the cash receipts from factoring were a stated driver of the FY25 OCF increase. Economically, this is a bank loan classified as customer collection — a textbook C1 cash-flow shenanigan even when GAAP-permissible.
Metric Hygiene
Management's own preferred metrics tilt toward operational milestones (cost-per-watt, module backlog, US-made volume) rather than reconciling cleanly to GAAP earnings or cash flow. The forensic concern is not deception — disclosure is mostly there — but framing.
The bonus plan's structure is the single most informative governance signal in the file. The threshold metric strips production start-up and underutilization — which means the bonus is essentially calibrated to the steady-state, fully-utilized US fleet, not to the actual mixed P&L of a company ramping its fourth, fifth, and sixth US factories simultaneously. That is not a violation, but it does explain why the equity story has been told as a 40%+ gross-margin business when the underlying module economics absent IRA and tariff support are closer to high-single-digit margins.
What to Underwrite Next
The accounting risk on this file is not "fraud potential." It is policy-and-customer concentration risk dressed in clean financials. The diligence checklist is concrete and time-bound.
Signal that would downgrade the grade. A single quarter showing (a) an expected-credit-loss provision above $50M, (b) a second customer-default lawsuit at materiality similar to BP/Lightsource, (c) any restatement, material-weakness disclosure, or change in revenue-recognition policy, or (d) the loss of any of the existing 45X transferee counterparties at higher discount rates would push this file to High (61-80).
Signal that would upgrade the grade. Two consecutive quarters of DSO falling below 90 days without a corresponding step-up in factoring volume, full collection of the BP/Lightsource receivable, FY26 disclosure breaking out 45X benefit and ex-45X gross margin in a clean reconciliation, and Series 7 warranty experience landing at or below the booked $50M would move the file to Watch (21-40).
Bottom line. This is not a thesis-breaking accounting file, but it is a position-sizing limiter and a clear case for refusing to pay multiples that imply the FY2024-2025 gross-margin profile is durable. The forward earnings power on a no-45X, no-tariff-protection basis is materially below the consensus run-rate. Treat the financials as accurate, the disclosures as adequate, and the economics as policy-dependent — that combination warrants a haircut rather than a "no."